{Reference Type}: Journal Article
{Title}: Induction of Fungal Secondary Metabolites by Co-Culture with Actinomycete Producing HDAC Inhibitor Trichostatins.
{Author}: Hwang GJ;Roh J;Son S;Lee B;Jang JP;Hur JS;Hong YS;Ahn JS;Ko SK;Jang JH;
{Journal}: J Microbiol Biotechnol
{Volume}: 33
{Issue}: 11
{Year}: 2023 Nov 28
{Factor}: 3.277
{DOI}: 10.4014/jmb.2301.01017
{Abstract}: A recently bioinformatic analysis of genomic sequences of fungi indicated that fungi are able to produce more secondary metabolites than expected. Despite their potency, many biosynthetic pathways are silent in the absence of specific culture conditions or chemical cues. To access cryptic metabolism, 108 fungal strains isolated from various sites were cultured with or without Streptomyces sp. 13F051 which mainly produces trichostatin analogues, followed by comparison of metabolic profiles using LC-MS. Among the 108 fungal strains, 14 produced secondary metabolites that were not recognized or were scarcely produced in mono-cultivation. Of these two fungal strains, Myrmecridium schulzeri 15F098 and Scleroconidioma sphagnicola 15S058 produced four new compounds (1-4) along with a known compound (5), demonstrating that all four compounds were produced by physical interaction with Streptomyces sp. 13F051. Bioactivity evaluation indicated that compounds 3-5 impede migration of MDA-MB-231 breast cancer cells.